Pain Management

>

Latest News

New FDA Guidance Seeks to Expand Nonopioid Options to Manage Chronic Pain and Curb Misuse / image credit FDA logo ©muhammed/stock.adobe.com
New FDA Guidance Seeks to Expand Nonopioid Options to Manage Chronic Pain and Curb Misuse

September 12th 2025

Opioids are still prescribed to 1 in 5 US adults with chronic pain because effective alternatives are not available; the FDA guidance supports enhanced research paradigms.

FDA Approves First New Treatment for Fibromyalgia in Over 15 Years: Daily Dose / image credit: ©New Africa/AdobeStock
FDA Approves First New Treatment for Fibromyalgia in Over 15 Years: Daily Dose

August 29th 2025

New Fibromyalgia Treatment: FDA Approves Once-Daily Nonopioid Analgesic TNX-102 SL
New Fibromyalgia Treatment: FDA Approves Once-Daily Nonopioid Analgesic TNX-102 SL

August 15th 2025

Vertex VX-993 Misses Primary Endpoint in Mid-Stage Trial, Ending Acute Pain Investigation
Vertex VX-993 Misses Primary Endpoint in Mid-Stage Trial, Ending Investigation for Acute Pain

August 5th 2025

FDA Mandates Major Changes to Opioid Labeling / image credit ©Steve Heap/stock.adobe.com
FDA Mandates Major Changes to Opioid Labeling

August 4th 2025

Latest CME Events & Activities
<1
...
1617181920
© 2025 MJH Life Sciences

All rights reserved.